A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00724334
Recruitment Status : Completed
First Posted : July 29, 2008
Last Update Posted : March 17, 2016
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2014
  Study Completion Date : May 2014
  Certification/Extension First Submitted : February 17, 2016